Cargando…
Sost Deficiency does not Alter Bone’s Lacunar or Vascular Porosity in Mice
SCLEROSTIN (Sost) is expressed predominantly in osteocytes acting as a negative regulator of bone formation. In humans, mutations in the SOST gene lead to skeletal overgrowth and increased bone mineral density, suggesting that SCLEROSTIN is a key regulator of bone mass. The function of SCLEROSTIN as...
Autores principales: | Mosey, Henry, Núñez, Juan A., Goring, Alice, Clarkin, Claire E., Staines, Katherine A., Lee, Peter D., Pitsillides, Andrew A., Javaheri, Behzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769812/ https://www.ncbi.nlm.nih.gov/pubmed/29349060 http://dx.doi.org/10.3389/fmats.2017.00027 |
Ejemplares similares
-
Sost Haploinsufficiency Provokes Peracute Lethal Cardiac Tamponade without Rescuing the Osteopenia in a Mouse Model of Excess Glucocorticoids
por: Javaheri, Behzad, et al.
Publicado: (2019) -
Phospho1 deficiency transiently modifies bone architecture yet produces consistent modification in osteocyte differentiation and vascular porosity with ageing
por: Javaheri, B., et al.
Publicado: (2015) -
Regulation of the Bone Vascular Network is Sexually Dimorphic
por: Goring, Alice, et al.
Publicado: (2019) -
Raman spectroscopy links differentiating osteoblast matrix signatures to pro-angiogenic potential
por: Sharma, Aikta, et al.
Publicado: (2019) -
A Computed Microtomography Method for Understanding Epiphyseal Growth Plate Fusion
por: Staines, Katherine A., et al.
Publicado: (2018)